This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
p27/Kip1 Antibody (SX53G8)
catalog :
NBP2-32889
quantity :
0.02 mg
price :
149 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
SX53G8
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunocytochemistry, flow cytometry, immunohistochemistry - paraffin section
citations: 1
product information
brand :
Novus
master code :
NBP2-32889
SKU :
NBP2-32889-0.02mg
product name :
p27/Kip1 Antibody (SX53G8)
description :
The p27/Kip1 Antibody (SX53G8) from Novus Biologicals is a mouse monoclonal antibody to p27/Kip1. This antibody reacts with human, mouse, rat, primate. The p27/Kip1 Antibody (SX53G8) has been validated for the following applications: Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.
target :
p27/Kip1
category :
Primary Antibodies
unit size :
0.02 mg
buffer :
10 mM PBS with 0.05% BSA
clonality :
Monoclonal
clone :
SX53G8
concentration :
0.2 mg/ml
conjugate :
Unconjugated
host :
Mouse
immunogen :
Purified GST-p27 fusion protein of human origin
isotype :
IgG1 Kappa
purity :
Protein A purified
species :
Human, Mouse, Rat, Primate
specificity :
This MAb recognizes a 27kDa protein, identified as the p27Kip1, a cell cycle regulatory mitotic inhibitor. It is highly specific and shows no cross-reaction with other related mitotic inhibitors. In Western blotting of cell lysates from 7 human breast cancer cell lines (ZR75-1, ZR75-30, MCF-7, MDAMB453, T47D, CAL51, 734B), the antibody labels a single band corresponding to p27Kip1. It functions as a negative regulator of G1 progression and has been proposed to function as a possible mediator of TGF- induced G1 arrest. p27Kip1 is a candidate tumor suppressor gene. Reportedly, low p27 expression has been associated with unfavorable prognosis in renal cell carcinoma, colon carcinoma, breast carcinomas, non-small-cell lung carcinoma, hepatocellular carcinoma, multiple myeloma, and lymph node metastases in papillary carcinoma of the thyroid, as well as a more aggressive phenotype in carcinoma of the cervix.
gene symbol :
CDKN1B
catalog number base :
NBP2-32889
accessionNumbers :
P46527
applications :
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin
2020 USD :
129
2021 USD :
149 USD
alt names :
CDKN4, cyclin-dependent kinase inhibitor 1B, cyclin-dependent kinase inhibitor 1B (p27, Kip1), Cyclin-dependent kinase inhibitor p27, KIP1P27KIP1, MEN1B, MEN4, p27Kip1
storage :
Store at 4C.
company information

Novus Biologicals
8100 Southpark Way, A-8
Littleton, CO 80120
Littleton, CO 80120
novus@novusbio.com
https://www.novusbio.com3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.
questions and comments